Point72 Asset Management L.P. 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 7:55 pm Sale | 2024-09-30 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Point72 Asset Management L.P. | 2,300,643 2.900% | -1,116,257 (-32.67%) | Filing |
| 2024-02-14 4:14 pm Sale | 2023-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Point72 Asset Management L.P. | 3,416,900 5.100% | -311,052 (-8.34%) | Filing |
| 2023-09-18 4:24 pm Purchase | 2023-09-15 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Point72 Asset Management L.P. | 3,727,952 5.600% | 3,727,952 (New Position) | Filing |